Taken together, these results demonstrate that metformin treatment efficiently inhibits the tumorigenesis of PCK1-KO hepatoma cells in nude mice through the AMPK/p27Kip1 axis. This evidence concerns the gene CDKN1B and hepatocellular carcinoma.